Investors

Printer Friendly Version View printer-friendly version
Download PDF Download PDF
BrainStorm Cell Therapeutics to Present at the BIO CEO & Investor Conference

HACKENSACK, N.J. and PETACH TIKVAH, Israel, Feb. 6, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today that Chaim Lebovits, President & Chief Executive Officer, will provide a corporate overview at the BIO CEO & Investor Conference, being held February 12-13 at the New York Marriott Marquis Hotel in New York City.

Logo - hi-res

BIO CEO & Investor Conference Presentation Details

Date:

Monday, February 12

Time:

2:00pm Eastern Time

Location:

New York Marriott Marquis, Wilder Room

Webcast:

https://goo.gl/Dj4Dvc

About BrainStorm Cell Therapeutics Inc.
BrainStorm Cell Therapeutics Inc. is a biotechnology company engaged in the development of first-of-its-kind adult stem cell therapies derived from autologous bone marrow cells for the treatment of neurodegenerative diseases. The Company holds the rights to develop and commercialize its NurOwn® technology through an exclusive, worldwide licensing agreement with Ramot, the technology transfer company of Tel Aviv University. NurOwn® has been administered to approximately 75 patients with ALS in clinical trials conducted in the United States and Israel.  In a randomized, double-blind, placebo-controlled clinical trial conducted in the U.S., a clinically meaningful benefit was demonstrated by a higher response to NurOwn® compared with placebo. For more information, visit the company's website at www.brainstorm-cell.com.

CONTACTS
Corporate:
Uri Yablonka
Chief Business Officer
BrainStorm Cell Therapeutics Inc.
Phone: 646-666-3188
uri@brainstorm-cell.com

Investors:
Michael Rice
LifeSci Advisors LLC
Phone: 646-597-6979
mrice@lifesciadvisors.com

Media:
Matt Middleman, M.D.
LifeSci Public Relations, LLC
Phone: 646-627-8384
matt@lifescipublicrelations.com

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/brainstorm-cell-therapeutics-to-present-at-the-bio-ceo--investor-conference-300594015.html

SOURCE BrainStorm Cell Therapeutics Inc.